Transient Macrophage Depletion Circumvents Scavenging and Redirects Biodistribution of mRNA-Lipid Nanoparticles

被引:0
|
作者
Yuan, Zhefan [1 ]
Luozhong, Sijin [1 ]
Li, Ruoxin [1 ]
Gu, Wenchao [1 ]
Chen, Yu [2 ]
Bhashyam, Dani [1 ]
Lai, Rachel [3 ]
Jiang, Shaoyi [1 ]
机构
[1] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA
[2] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA
[3] Cornell Univ, Smith Sch Chem & Biomol Engn, Ithaca, NY 14853 USA
关键词
macrophage depletion; lipid nanoparticle; mRNAdelivery; enhanced efficiency; redirect biodistributions; IN-VIVO; DELIVERY; CELLS; EXPRESSION; MONOCYTES; POTENT; BRAIN;
D O I
10.1021/acsnano.5c02001
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The mononuclear phagocytic system is recognized as a major scavenger of mRNA-lipid nanoparticles (LNPs), clearing and redirecting these particles away from their intended targets and thus diminishing their delivery efficacy. Understanding the mechanism by which mRNA-LNPs interact with phagocytes and how this interaction affects the mRNA transfection is critical to enhancing the delivery of mRNA. In this study, we temporarily depleted both circulating and resident macrophages (MF) and evaluated the transfection efficiency and biodistribution of mRNA-LNPs. We first demonstrated the enhanced liver expression using two liver-tropic formulations and the significant improvement of the in vivo gene editing efficiency of CRISPR-Cas9 in the Ai14 mouse model after MF depletion, providing a versatile strategy for enhanced mRNA delivery to the liver regardless of the formulation employed. We then extended our investigations to lung-tropic and lymphoid-tropic LNP formulations and discovered that MF depletion abolishes the targeting capacities of these non-liver-tropic formulations, providing insights into the organ targeting of LNPs. Finally, we screened and compared various clinically relevant MF depletion methods, providing the translation potential of this method on enhanced hepatic delivery of mRNA.
引用
收藏
页数:12
相关论文
共 39 条
  • [21] Macrophage-targeted Mms6 mRNA-lipid nanoparticles promote locomotor functional recovery after traumatic spinal cord injury in mice
    Fu, Chunyan
    Jin, Xiaoqin
    Ji, Kangfan
    Lan, Ke
    Mao, Xingjia
    Huang, Zhaobo
    Chen, Jian
    Zhao, Fengdong
    Li, Pengfei
    Hu, Xuefei
    Sun, Liwen
    Lu, Ning
    Zhong, Jinjie
    Chen, Yingying
    Wang, Linlin
    SCIENCE ADVANCES, 2025, 11 (13):
  • [22] Cartilage-targeting mRNA-lipid nanoparticles rescue perifocal apoptotic chondrocytes for integrative cartilage repair
    Yu, Xinning
    Xu, Tengjing
    Shi, Huimin
    Hong, Jianqiao
    Jin, Xiaoqiang
    Cao, Le
    Wang, Jiajie
    Lin, Yunting
    Pan, Zongyou
    Wang, Siheng
    Fang, Jinghua
    Xu, Kaiwang
    Song, Hongyun
    Zhou, Zhuxing
    Zhu, Sunan
    Yin, Jun
    Qi, Yiying
    Dai, Xuesong
    CHEMICAL ENGINEERING JOURNAL, 2023, 465
  • [23] Molecular Dynamics Simulation Studies of Bile, Bile Salts, Lipid-Based Drug Formulations, and mRNA-Lipid Nanoparticles: A Review
    Guruge, Amali G.
    Warren, Dallas B.
    Pouton, Colin W.
    Chalmers, David K.
    MOLECULAR PHARMACEUTICS, 2023, 20 (06) : 2781 - 2800
  • [24] Enhancing mRNA-lipid nanoparticles formulations to improve transfection efficiency in macrophages and dendritic cells in cancer immunotherapy
    Alshehry, Yasir
    Fernandez, Matthew
    Aldaqqa, Raneem
    Al-Terawi, Asma
    Sweet, Douglas
    da Rocha, Sandro
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Immunotherapeutic effects of specific and nonspecific mRNA-lipid nanoparticles in a mouse model of HDM-induced airway inflammation
    Thanasarnthungcharoen, Chanatip
    Chanasit, Supapich
    Fievez, Laurence
    Kaewamatawong, Theerayuth
    Patniboon, Piyachat
    Lin, Paulo J. C.
    Bureau, Fabrice
    Jacquet, Alain
    ALLERGY, 2024, 79 (07) : 1974 - 1978
  • [26] Biodistribution of Lipid 5, mRNA, and Its Translated Protein Following Intravenous Administration of mRNA-Encapsulated Lipid Nanoparticles in RatsS
    Ci, Lei
    Hard, Marjie
    Zhang, Hannah
    Gandham, Srujan
    Hua, Serenus
    Wickwire, John
    Wehrman, Tod
    Slauter, Richard
    Auerbach, Andrew
    Kenney, Matthew
    Mercer, Greg
    Hendrick, Tracy
    Almarsson, Orn
    Cheung, Eugene
    Burdette, Douglas
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (07) : 813 - 823
  • [27] Characterization and associated pressure-dependent behavior of deposits formed during sterile filtration of mRNA-Lipid nanoparticles
    Messerian, Kevork Oliver
    Zverev, Anton
    Kramarczyk, Jack F.
    Zydney, Andrew L.
    JOURNAL OF MEMBRANE SCIENCE, 2023, 684
  • [28] Encapsulation of Dexamethasone into mRNA-Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies
    Rivero Berti, Ignacio
    Gambaro, Rocio Celeste
    Limeres, Maria Jose
    Huck-Iriart, Cristian
    Svensson, Malin
    Fraude-El Ghazi, Silvia
    Pretsch, Leah
    Si, Shutian
    Lieberwirth, Ingo
    Landfester, Katharina
    Cacicedo, Maximiliano Luis
    Islan, German Abel
    Gehring, Stephan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [29] Process development of tangential flow filtration and sterile filtration for manufacturing of mRNA-lipid nanoparticles: A study on membrane performance and filtration modeling
    Wu, Wenjun
    Oliveira, Liliam Teixeira
    Jain, Aarushi
    Karpov, Yury
    Olsen, Kirstin
    Wu, Yu
    Panicker, Rajesh Krishnan Gopalakrishna
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 675
  • [30] Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration
    Labonia, M. C. I.
    Senti, M. Estape
    van der Kraak, P. H.
    Brans, M. A. D.
    Dokter, I.
    Streef, T. J.
    Smits, A. M.
    Deshantri, A. K.
    de Jager, S. C. A.
    Schiffelers, R. M.
    Sluijter, J. P. G.
    Vader, P.
    JOURNAL OF CONTROLLED RELEASE, 2024, 369 : 734 - 745